Ann: MedAdvisor Completes $8M Oversubscribed Capital Raising-MDR.AX, page-3

Nice. CR price 4.0c. Only a 10% discount. Normally instos want 15% or more! Well done Management.

I've seen plenty of of shares drop below the CR price in 2016 (VOC, NTC, AJM).

200M shares is a lot to add to the market so hopefully MDR can weather the storm a bit better and we see the sophs holding for large profits rather than opportunistic pips.

The Placement was significantly over subscribed and required a scale back. Strong interest was received from existing and new investors, with a number of new and leading Australian institutions joining the shareholder register. Key pharmacy groups also participated in the Placement, providing industry recognition and positive validation of MedAdvisor’s offering. The Placement was led by joint managers Peloton Capital and Veritas Securities.

When is a CR ever under subscribed?